Published in BMJ Evidence-Based Medicine · View the paper (DOI)
Women with premenstrual syndrome (PMS) experience reduced symptom intensity and interference in their lives when taking open-label placebos, especially when provided with a treatment explanation. The study found significant reductions in PMS symptoms and side effects, suggesting an acceptable and efficacious intervention.
Coverage from 2 institutions